GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for uracil phosphoribosyltransferase (B2RIV3)

Analyse AlphaFold monomer V2.0 prediction for uracil phosphoribosyltransferase (B2RIV3) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B2RIV3
Type
protein
Length
216 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x7012c0b45c68a2c067644b9d3e5DDa06892c6957
Molecule
Uracil phosphoribosyltransferase
UniProt
B2RIV3
Pockets
2 · best druggability 0.69

Structure

1 distinct chain · 32% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUracil phosphoribosyltransferaseprotein21632% helix, 36% strandB2RIV3

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12380.690.8531empty
2780.340.7517empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.